We navigate you through the healthcare market.

FAQ-Reihe: Hybrid-DRGs

FAQ series: Hybrid-DRGs

FAQ series: Hybrid-DRGs

What was meant as a groundbreaking overhaul of the German healthcare market is now creating a massive upset of the system. Find out more about the effects of the German healthcare reform KHVVG.

The Federal Institute for Drugs and Medical Devices in Germany (BfArM) published the final version of the ICD-10-GM for 2026.

Federal Health Minister Nina Warken plans to discontinue the hospital atlas. The atlas was introduced only in May 2024.

For manufacturers of innovative technologies, it is crucial to know which players are involved in the NUB process and how to submit a successful application.

The NUB procedure, according to section 6 para. 2 KHEntgG (Hospital Remuneration Act) allows hospitals to negotiate extrabudgetary reimbursement for new diagnostic and treatment methods with payers. Its primary purpose is to bridge the so-called…

For the next eight weeks you have the opportunity to receive reimbursement for your innovative therapy though the NUB application process.